Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas.
Gamma Knife radiosurgery is often used in pituitary adenomas. Aim of our study is to describe the characteristics and long-term outcome of patients with adenoma recurrence after Gamma Knife radiosurgery. We conducted a retrospective analysis of patients with pituitary adenoma treated by Gamma Knife radiosurgery between 1994 and 2014. Tumor recurrence was labeled as "in field" when the tumor growth occurred adjacent or within the prescribed isodose, whereas it was classified as "out of field" when the tumor growth occurred outside the prescribed isodose. Five hundred forty-three patients were included, 272 (50.1 %) had a nonfunctioning pituitary adenoma (NFPA) and 271 (49.9 %) patients had a hormone secreting-pituitary adenoma. The median follow-up after GKRS was 78 months (IQR, 36-125 months). Thirty-nine patients (7.2 %) had recurrence of disease and it was more frequent in patients with NFPA than in patients with hormone secreting adenomas (9.6 % vs. 4.8 %). The 10-yr progression-free survival in patients with NFPA was 78.7 % (95 % CI 69.5 - 87.9 %), as compared with 93.3 % (95 % CI 89.3 - 97.3 %; p < 0.01) in hormone secreting adenomas. Tumor recurrence was "in field" in 17 cases (43.6 %) and "out of field" in 22 cases (56.4 %). Seven of the 39 patients with recurrence died despite further treatments. Six of these patients had an "in field" recurrence. Recurrence of a pituitary adenoma after GKRS may occur several years after initial treatment. Distinction between "in field" and "out of field" tumor recurrence probably reflects two different pathophysiological mechanisms and may have prognostic importance.
From the Department of Neurosurgery, Milan, Italy. losa.marco@hsr.it.
Marco
M
Losa
From the Department of Neurosurgery, Milan, Italy.
Giorgio
G
Spatola
From the Department of Neurosurgery, Milan, Italy.
Luigi
L
Albano
Department of Endocrinology and Metabolic Disease, Milan, Italy.
Alessandra
A
Gandolfi
Department of Medical Physics Department, Milan, Italy.
Antonella
A
Del Vecchio
Department of Radiotherapy, Istituto Scientifico San Raffaele, Vita-Salute University, Milan, Italy.
Angelo
A
Bolognesi
From the Department of Neurosurgery, Milan, Italy.
Pietro
P
Mortini
D000236:Adenoma / Q000473:pathology* / Q000601:surgery; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D010911:Pituitary Neoplasms / Q000473:pathology* / Q000601:surgery; D016634:Radiosurgery / Q000295:instrumentation*; D012086:Reoperation; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
Pituitary neoplasm; Pituitary surgery; Radiosurgery; Radiotherapy
J Neurosurg. 2004 Mar;100(3):438-44
15035279
J Exp Clin Cancer Res. 2009 Mar 11;28:36
19284583
Prog Neurol Surg. 2009;22:77-95
18948721
J Clin Endocrinol Metab. 2008 Jul;93(7):2546-52
18413424
Endocrine. 2016 Jul;53(1):28-34
27066792
J Neurosurg. 2002 Dec;97(5 Suppl):429-32
12507069
J Clin Endocrinol Metab. 2009 Sep;94(9):3400-7
19509108
J Neurosurg. 2005 Apr;102(4):678-91
15871511
Neurosurgery. 2008 Jun;62(6):1271-6; discussion 1276-8
18824993
Acta Neurochir (Wien). 2007 Oct;149(10):999-1006; discussion 1006
17676409
J Neurosurg. 2016 Jul;125(1):202-12
26517773
J Neurosurg. 2013 Aug;119(2):446-56
23621595
Pituitary. 2013 Mar;16(1):68-75
22302560
Eur J Endocrinol. 2007 Jan;156(1):91-8
17218730
J Clin Endocrinol Metab. 2014 Apr;99(4):1273-81
24471574
J Neurosurg. 2008 Mar;108(3):525-32
18312100
J Neurooncol. 2016 Feb;126(3):519-25
26614517
Rev Endocr Metab Disord. 2009 Jun;10(2):135-44
18787957
J Neurosurg. 2006 Jun;104(6):876-83
16776330
J Neurosurg. 2013 Dec;119(6):1486-92
23930850
Neurosurgery. 2003 Jul;53(1):51-9; discussion 59-61
12823873
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1325-9
18029107
Pituitary. 2009;12(3):211-6
19152112